Learn more about whether Ionis Pharmaceuticals, Inc. or Neurocrine Biosciences, Inc. is a better investment based on AAII's ...

Learn more about whether Neurocrine Biosciences, Inc. or PTC Therapeutics, Inc. is a better investment based on AAII's A+ ...

Halozyme announces US FDA approval of argenx's Vyvgart Hytrulo prefilled syringe co-formulated with ENHANZE for self-injection for gMG and CIDP: San Diego Monday, April 14, 2025, ...

Hutchmed (China) is evaluating supply-chain options for a blood-cancer drug recently approved by Beijing to mitigate impact ...

Ironwood Pharmaceuticals has been left considering its options after the FDA demanded another phase 3 trial before it will ...

The psoriasis pipeline possesses some drugs in mid- and late-stage development to be approved in the near future. The emerging landscape holds a dive ...

The "Deep Dive into Renewable Energy Procurement" report has been added to ResearchAndMarkets.com's offering.This report looks at the different procurement methods companies can use when adopting ...

Over the past two decades, I’ve observed significant shifts in the life sciences, pharmaceutical, and CDMO landscape. Pharmaceutical companies and their outsourcing partners must continuously ...

Researching and developing therapeutic products for human use.